US 12161717
CD38 modulating antibody agents
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 12161717 (CD38 modulating antibody agents) held by BLACK BELT THERAPEUTICS LIMITED expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BLACK BELT THERAPEUTICS LIMITED
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00